Significance of Expression of CD_(14)~+ CD_(16)~+ on Peripheral Monocytes in Children with Kawasaki Disease
Renye Ding
Abstract
Renye Ding
Abstract
Objective To observe the significance of expressions of CD14+CD16+ on peripheral monocytes in children with Kawasaki di-sease (KD).Methods The expression of CD14+ and CD14+CD16+ monocytes in 16 children with KD (1-11 years old) were analyzed by flow cytomety both pre-treatment and post-treatment.And the percentages of CD14+CD16+ monocytes among CD14+ monocytes were calculated.Sixteen healthy children (10 months -10 years old) were served as normal control group.Statistical analysis was performed using t test.Results The levels of CD14+ monocytes,percentage of CD14+CD16+ monocytes among CD14+ monocytes and CD14+CD16+ monocytes in children with KD during acute phase (n=16) were (1.03±0.58)×109 L-1,(12.53±5.31)% and(1.20±0.79)×108 L-1.They were significantly higher than those in the normal controls[(0.57±0.21)×109 L-1,(3.86±1.84)% and (0.21±0.10)×108 L-1](Pa0.05).Followed by the patients' condition improved(n=15), the increased expressive levels[(1.03±0.60) ×109 L-1,( 12.83±6.51)%,(1.22±0.82)×108 L-1] decreased [(0.49±0.21)×109 L-1,(5.07±4.77)%,(0.24±0.20)×108 L-1)(Pa0.01)].The expressive levels of CD14+CD16+ monocytes were no significant differences between the post-treatment and the normal controls(Pa0.05).And the expressive levels remained high when the patient recurred.Conclusions The expressive levels of CD14+CD16+ monocytes increase in children with KD.And they change when the patient's clinical condition change.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the significance of expressions of CD14+CD16+ on peripheral monocytes in children with Kawasaki di-sease (KD).Methods The expression of CD14+ and CD14+CD16+ monocytes in 16 children with KD (1-11 years old) were analyzed by flow cytomety both pre-treatment and post-treatment.And the percentages of CD14+CD16+ monocytes among CD14+ monocytes were calculated.Sixteen healthy children (10 months -10 years old) were served as normal control group.Statistical analysis was performed using t test.Results The levels of CD14+ monocytes,percentage of CD14+CD16+ monocytes among CD14+ monocytes and CD14+CD16+ monocytes in children with KD during acute phase (n=16) were (1.03±0.58)×109 L-1,(12.53±5.31)% and(1.20±0.79)×108 L-1.They were significantly higher than those in the normal controls[(0.57±0.21)×109 L-1,(3.86±1.84)% and (0.21±0.10)×108 L-1](Pa0.05).Followed by the patients' condition improved(n=15), the increased expressive levels[(1.03±0.60) ×109 L-1,( 12.83±6.51)%,(1.22±0.82)×108 L-1] decreased [(0.49±0.21)×109 L-1,(5.07±4.77)%,(0.24±0.20)×108 L-1)(Pa0.01)].The expressive levels of CD14+CD16+ monocytes were no significant differences between the post-treatment and the normal controls(Pa0.05).And the expressive levels remained high when the patient recurred.Conclusions The expressive levels of CD14+CD16+ monocytes increase in children with KD.And they change when the patient's clinical condition change.
Key concepts: CD14, CD16, Kawasaki disease, Monocyte, Medicine, Immunology, Peripheral, Internal medicine